Stephen K. Smith is an internationally renowned clinician-scientist and Professor of Obstetrics and Gynaecology at Imperial College London, United Kingdom. He is also associated with MirZyme Therapeutics Ltd., Birmingham, United Kingdom, where he continues to advance translational research in vascular biology and women’s health.
Professor Smith is a pioneer in reproductive medicine, obstetrics, placental biology, and angiogenesis. His research has significantly advanced the understanding of the molecular mechanisms underlying pregnancy complications, particularly preeclampsia, implantation, and placental vascular development. He has published extensively in leading international journals and has made substantial contributions to the development of novel therapeutic approaches for maternal and fetal disorders.
His current research focuses on vascular signaling pathways, including the VEGF–HO-1–CSE axis, with the goal of developing innovative treatments for preeclampsia and other pregnancy-related vascular diseases. His work continues to bridge fundamental science and clinical medicine, improving maternal and neonatal health worldwide.